Gangagen Biotechnologies Is A Clinical Stage Biotechnology Company Founded In India In 2000 And Incorporated In The Us In 2001 By Drjramachandranthe Company Focuses On Developing Novel Therapeutic Proteins To Combat Infectious Diseasesparticularly Those Caused By Antibiotic Resistant Bacteriagangagen Aims To Address Significant Public Health Threats Posed By Drug Resistant Infections Through Innovative Research And Development The Company S Product Pipeline Includes Ectolysinssuch As The Lead Protein P128Which Targets And Kills Staphylococcusincluding Methicillin Resistant Strainsadditionallygangagen Develops Klebicinsengineered Antibiotic Proteins Designed To Treat Multidrug Resistant Klebsiella Pneumoniaethese Products Utilize Unique Mechanisms To Specifically Target Pathogens While Preserving The Microbiome Gangagen Has Received Funding From Organizations Like Carb X To Support Its Development Efforts And Has Filed 16 Patents Related To Antibiotics And Bacterial Diseaseswith Operations In Bangaloreindiaand A Presence In The Usgangagen Is Committed To Advancing Antibacterial Therapies To Meet Critical Healthcare Needs
